Patoloxía Molecular das Doenzas Raras
PatMol-DR
University of Mississippi Medical Center
Jackson, Estados UnidosPublicacións en colaboración con investigadores/as de University of Mississippi Medical Center (2)
2022
-
Efficacy of empagliflozin in heart failure with preserved versus mid-range ejection fraction: a pre-specified analysis of EMPEROR-Preserved
Nature Medicine, Vol. 28, Núm. 12, pp. 2512-2520
2021
-
Empagliflozin in heart failure with a preserved ejection fraction
New England Journal of Medicine, Vol. 385, Núm. 16, pp. 1451-1461